Sector Chart Finch Therapeutics Group, Inc.

Stocks

FNCHQ

US31773D2009

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 12:12:23 2026-07-09 EDT			5-day change	1st Jan Change
10.55 ^USD	+0.29%		+0.48%	-21.78%

04-26	Acurx Pharmaceuticals, Inc., Adiso Therapeutics, Inc., Summit Therapeutics Inc., Finch Therapeutics Group, Inc. and Astrazeneca plc Announces Clostridium Difficile Infections Clinical Trial Updates	CI
03-26	Motion for Joint Administration Approved for Finch Therapeutics Group, Inc.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
FINCH THERAPEUTICS GROUP, INC.	16.94M	-	-	-	-	-
LONZA GROUP AG	50.73B
REVOLUTION MEDICINES, INC.	39.73B	-	-	-	-	-
IQVIA HOLDINGS INC.	34.69B
BEONE MEDICINES AG	33.21B
CELLTRION, INC.	26.76B